| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorinostat:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |